CMS/FDA Parallel Review: Agencies Weighing Process For Planning Trials That Satisfy Both
This article was originally published in The Pink Sheet Daily
Executive Summary
The two agencies request public comment on how such a process should be established in a Sept. 17 notice announcing their intention to explore a voluntary parallel review program for drugs and medical devices in earnest.